Maluuba's Machine Literacy Model Beats Facebook, Google and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Maluuba's Machine Literacy Model Beats Facebook, Google and IBM in CBT and CNN Dataset Tests

MONTREAL, QC--(Marketwired - Jun 8, 2016) - Maluuba, a Canadian deep-learning company helping machines think, reason and communicate with human-like intelligence, today announced it has scored the highest results to date on the premier machine comprehension benchmarks: Facebook's CBT (Children's Book Test) dataset and Deepmind's CNN dataset. Maluuba's model achieved leading scores of 67.4 percent and 74.0 percent accuracy on the respective datasets, surpassing top results from leaders in the academic Natural Language Processing (NLP) community including Facebook, Google and IBM Watson.

Machine comprehension is evaluated by posing a set of questions based on a text passage, then scoring a system's answers for accuracy. The CBT and CNN datasets are the new benchmarks for testing the role of memory and context in language processing and understanding. They consist of a set of texts and related questions drawn from those texts, and the correct answers.

The CBT dataset uses text from 20-sentence excerpts from children's books available through Project Gutenberg. Questions are formed by taking the 21st sentence of an excerpt and deleting one of its words, such that the sentence becomes a fill-in-the-blank-style question. Maluuba's model, called the EpiReader (based on the Philosopher Epicurus' principle of Multiple Explanations), achieved a leading score of 67.4 percent on the CBT dataset. The model answers a question by testing multiple hypotheses and selecting the most accurate answer based on context, mimicking how humans make context-based decisions every day. To put this in perspective, Facebook's CBT accuracy currently stands at 63 percent with IBM Watson at 63.4 percent.

The CNN dataset is built using articles from the CNN website. The articles themselves form the text, and questions are generated from short summary statements that accompany each article. In this test, Maluuba's EpiReader achieved a leading score of 74.0 percent. DeepMind's CNN accuracy to date is 63.8 percent with Facebook topping off at 66.8 percent and IBM Watson at 69.5 percent.

"These results mean that our technology can comprehend what is happening in text and start to form an understanding based on what was read," said Sam Pasupalak, cofounder and CEO of Maluuba. "Advancement on these datasets means that we are on track to helping machines understand and make sense of unstructured data, which opens up new frontiers for AI. This has always been our goal at Maluuba and our hope is that our results continue to spark progress in the industry."

Maluuba is working to solve fundamental problems in language understanding, with the aim of bringing us closer to machine literacy. This is a critical step in achieving true artificial intelligence. The company's research results on the CBT and CNN datasets demonstrate significant progress toward machine comprehension using a two-step, neural net-based model.

"Humans make predictions and sensible choices everyday based on context, but teaching machines to do this hasn't been accomplished quite yet. There are still hurdles for us to overcome in order for our machines to truly understand and interact with us as opposed to getting there by process of elimination," said Dr. Yoshua Bengio, professor at the University of Montreal and Maluuba advisor. "Maluuba's advancements in this space and their vision to teach machines true literacy is promising for the industry and consumers alike."

Read more about the EpiReader and its results here ; and watch the EpiReader in action here . For more information on Maluuba, visit: www.maluuba.com .

About Maluuba Founded in 2011, Maluuba is a Canadian A.I. company that has received over $9M in funding to develop the world's most advanced deep learning based language understanding platform in order to train machines to model decision-making capabilities of the human brain. Maluuba's machine literacy platform, utilizing breakthrough deep learning techniques in Question Answering and Conversational User Interfaces, is set to disrupt several billion dollar industries including Enterprise, Customer Service, E-Commerce and many more. Maluuba's engineering and customer operations are located in Waterloo, Ontario, with a research office in Montreal dedicated to solving fundamental problems in language understanding for innovative products that will further advance AI systems. For more information, visit: www.maluuba.com .

Contact Info: Melissa Roxas Inner Circle Labs for Maluuba Email Contact 415-684-9401

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading